ID: ALA5090132

Max Phase: Preclinical

Molecular Formula: C20H20ClN7O2S

Molecular Weight: 457.95

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1cccc2sc(NC(=O)[C@H]3CC[C@@H](n4cnc5c(N)nc(Cl)nc54)CC3)nc12

Standard InChI:  InChI=1S/C20H20ClN7O2S/c1-30-12-3-2-4-13-14(12)24-20(31-13)27-18(29)10-5-7-11(8-6-10)28-9-23-15-16(22)25-19(21)26-17(15)28/h2-4,9-11H,5-8H2,1H3,(H2,22,25,26)(H,24,27,29)/t10-,11+

Standard InChI Key:  XKVJSKYNSHUBAQ-PHIMTYICSA-N

Associated Targets(Human)

Choline kinase alpha 330 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Choline/ethanolamine kinase 45 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 457.95Molecular Weight (Monoisotopic): 457.1088AlogP: 4.05#Rotatable Bonds: 4
Polar Surface Area: 120.84Molecular Species: NEUTRALHBA: 9HBD: 2
#RO5 Violations: 0HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.98CX Basic pKa: 2.01CX LogP: 3.72CX LogD: 3.63
Aromatic Rings: 4Heavy Atoms: 31QED Weighted: 0.44Np Likeness Score: -1.53

References

1. Quartieri F, Nesi M, Avanzi NR, Borghi D, Casale E, Corti E, Cucchi U, Donati D, Fasolini M, Felder ER, Galvani A, Giorgini ML, Lomolino A, Menichincheri M, Orrenius C, Perrera C, Re Depaolini S, Riccardi-Sirtori F, Salsi E, Isacchi A, Gnocchi P..  (2021)  Identification of unprecedented ATP-competitive choline kinase inhibitors.,  51  [PMID:34416377] [10.1016/j.bmcl.2021.128310]

Source